Trial intelligence / Profile preview

Estradiol in Menopausal Depression

NCT01126801Phase 2Terminated

Sponsor
Massachusetts General Hospital
Start
May 2010
Primary completion
Feb 2011
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started May 2010; status: terminated.

02

Drugs

estradiol
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT01126801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01126801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call